The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision. The group at the time was ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Q3 2025 Earnings Call Feb 18, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Reports Q3 revenue $8.29B, consensus $8.33B. “We delivered strong earnings this quarter, with significant improvements in both our gross margin ...

(Reuters) - Medtronic (NYSE: MDT) beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for ...